Market Introduction
A bovine pericardial valve, also known as the bioprosthetic valve, is an artificial bioprosthetic cardiac valve with a three-cusp structure made from chemically treated bovine pericardium on a suitable framework of a metallic alloy such as a titanium frame which provides strength and elasticity. The pericardium is a double-layered, tough membrane that covers the heart. The porcine and bovine pericardium is harvested and processed as a biomaterial and used in various clinical applications. Bovine tissues are harvested from a sac surrounding the heart of a cow. Bovine pericardium valves are used as dural closure valves, bone, and dental membranes, surgical buttress, and bio-prosthetic heart valves.
Market Overview and Dynamics
The Europe bovine pericardial valve market is to reach US$ 1229.57 million by 2027 from US$ 604.77 million in 2019. The market is anticipated to grow at a CAGR of 9.4% during 2019–2027. Factors such as increasing incidence of cardiovascular diseases (CVD) and congenital heart diseases (CHD) and advantages of tissue-based heart valves over mechanical valves are expected to boost the growth of the bovine pericardial valve market. However, the market is likely to get impacted by the risk factor such as limitations of the tissue-based valve during the forecast period.
Key Market Segments
In terms of valve-type, the aortic segment accounted for the largest share of the Europe bovine pericardial valve market in 2019. Cobalt-chrome segment accounted for the largest share of the Europe bovine pericardial valve market, by alloy, in 2019. In terms of end-user, the hospitals segment accounted for the largest share of the Europe bovine pericardial valve market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Europe bovine pericardial valve market report are the World Health Organization (WHO), NICOR (National Institute for Cardiovascular Outcomes Research), National Health Services (NHS), World Bank, World Health Federation and others.
Reasons to buy report
- It provides understanding of the Europe, bovine pericardial valve market landscape and identifies bovine pericardial valve market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe bovine pericardial valve market.
- It helps efficiently plan merger and acquisition, and partnership deals in the bovine pericardial valve market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of bovine pericardial valve market performance of various segments pertaining to the Europe bovine pericardial valve market.
- It provides bovine pericardial valve market revenue forecast of the market based on various segments for the period from 2019 to 2027.
EUROPE BOVINE PERICARDIAL VALVE MARKET SEGMENTATION
By Valve Type
- Aortic
- Mitral
- Others
By Alloy
- Cobalt-chrome
- Titanium
- Nickel Molybdenum
- Others
By End-User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
By Country
- Japan
- China
- India
- South Korea
- Australia
Company Profiles
- AFFLUENT MEDICAL SA
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Medtronic
- LivaNova PLC
Europe Bovine Pericardial Valve Market Strategic Insights
Europe Bovine Pericardial Valve Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 604.77 Million |
| Market Size by 2027 | US$ 1229.57 Million |
| CAGR (2019 - 2027) | 9.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Valve Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Bovine Pericardial Valve Market Country and Regional Insights
